Co‐pathological connected primary neurons in a microfluidic device for alzheimer studies

Citations Over TimeTop 10% of 2011 papers

Abstract

Abstract This communication presents a novel experimental model for Alzheimer studies, where connected primary neurons were set into subtend, co‐pathological states. Cortical neurons were cultured in two separated cell compartments in a microfluidic device. A neurite network was generated in a main channel through the neurite outgrowth from both cell compartments. A gradient of okadaic acid (OA) is generated over this neurite network by perfusion. OA is a phosphatase inhibitor that induces hyperphosphorylation of Tau proteins, a major hallmark in Alzheimer disease. The local OA treatment resulted in a connected “diseased” and “healthy” cell population. Anti‐phosphorylated tau (Ser262) staining confirmed different states of phosphorylated Tau proteins, and synapthophysin staining the connection of “healthy” and “diseased” cells. Here, we present a novel in vitro model that opens the possibility to study cellular and molecular propagation mechanisms in neurodegeneration, in Tauopathies (as e.g., in Alzheimer), as well as simultaneous drug effects on connected healthy and diseased cell populations. Biotechnol. Bioeng. 2011;108:2241–2245. © 2011 Wiley Periodicals, Inc.

Related Papers

• → Okadaic acid induces tau phosphorylation in SH-SY5Y cells in an estrogen-preventable manner(2010)75 cited
• Tau hyperphosphorylation induces apoptotic escape and triggers neurodegeneration in Alzheimer＇s disease(2014)
• Hyperphosphorylation of retinoblastoma protein and p53 by okadaic acid, a tumor promoter.(1993)
• → Okadaic Acid, a Protein Phosphatase Inhibitor, Inhibits Nerve Growth Factor‐Directed Neurite Outgrowth in PC 12 Cells(1992)33 cited
• Lovastatin Attenuates Okadaic acid-induced Tau Protein Superphosphorylation in Rat Cortical Neurons(2008)